TOVX - Multiplikator P/S Synthetic Biologics

Tandha merek Theriva Corp (TOVX)

P/S multiple fluctuations on the GURU.Markets platform demonstrate that Theriva Biologics, Inc. (TOVX) quotes remain independent of macroeconomics, as the company's success relies on the progress of adenoviral drug trials. High patent margins ensure scalability, while asset value depends on patient survival rates and technology protection. The value of 21.80 indicates the current level of the business's market valuation.

TOVX (Synthetic Biologics) riwayat Rasio rega marang pendapatan saka 08.05.2026 nganti 17.11.2026

Synthetic Biologics (TOVX) - rincian metrik lan laporan keuangan

Analisis umum perusahaan:Theriva Biologics, TOVX
Produk asil prodhuksi Theriva Biologics Inc

Investors assess the operational strength of assets through the price-to-sales ratio, where low values signal undervaluation and inflated figures indicate speculative risk. By analyzing changes in the P/S multiple, one can correlate the business value of Theriva Biologics, Inc. (TOVX) with the efficiency of its academic R&D approach and the costs of PhD specialists, thereby determining the company's fundamental stability.

Perusahaan pesaing

Kapitalisasi marang pendapatan ImmunityBio Corp IBRX|Immunocore Holdings - Kapitalisasi marang pendapatan|Multiplikator P/S Janux Corp JANX|RCUS - Rasio rega marang pendapatan|ZYME (zymeworks.com) - Rasio kapitalisasi marang pendapatan|Tango Therapeutics Corp (TNGX) - Rasio rega marang pendapatan|Rega marang dodolan Iovance (IOVA)|Kapitalisasi marang pendapatan IMTX|XNCR - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan CMPX (Compass Bio)|Kapitalisasi marang volume dodolan REPL|Multiplikator P/S LYEL (Lyell Immunopharma, Inc.)|Rasio kapitalisasi pasar marang pendapatan IPHA|Pyxis - Multiplikator P/S|Rega marang dodolan Compugen|IO Biotech, Inc. (IOBT) - Rasio rega marang pendapatan|Sutro Biopharma, Inc. - Rasio kapitalisasi pasar marang pendapatan|INKT (minktherapeutics.com) - Multiplikator P/S|Multiplikator P/S werewolftx.com|Rasio rega marang pendapatan immixbio.com (IMMX)|ALXO: Rasio rega marang dodolan|Multiplikator P/S CUE (Cue Biopharma Inc.)|PDS Biotechnology (PDSB) - Rega marang dodolan|SONN - Rasio rega marang pendapatan|MAIA Biotechnology, Inc. (MAIA) - Kapitalisasi marang pendapatan|LIMN: Multiplikator P/S|LAVA Therapeutics N.V. (LVTX) - Multiplikator P/S|Kapitalisasi marang pendapatan NXTC|Multiplikator P/S leaptx.com|Multiplikator P/S INTS|Koefisien rega marang pendapatan Sensei Biotherapeutics, Inc.|Rasio rega marang pendapatan gritstonebio.com GRTS|Rasio kapitalisasi pasar marang pendapatan KA|NEXI - Rasio rega marang pendapatan|Turnstone Biologics Corp. - Kapitalisasi marang volume dodolan|VCNX: Multiplikator P/S|Rasio kapitalisasi marang pendapatan HARP